Hashemi, Seyed Yaser Momenabadi, Victoria Faramarzi, Ahmad Kiani, Amin
Published in
Archives of Public Health
BackgroundChronic obstructive pulmonary disease (COPD) is a heterogeneous disorder that progresses over time, and currently it is the fourth leading cause of death across the globe. The World Health Organization (WHO) predicts that the disease will become the third leading cause of death by 2030. The present study aimed to assess the burden trends ...
Xia, Ru-yu Hu, Xiao-yang Fei, Yu-tong Willcox, Merlin Wen, Ling-zi Yu, Ming-kun Zhang, Li-shan Dai, Meng-yuan Fei, Guang-he Thomas, Mike
...
Published in
BMC Complementary Medicine and Therapies
BackgroundChinese herbal medicine is widely used in combination with usual care for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) in China. Chinese patent medicine Shufeng Jiedu (SFJD) capsules is widely used for respiratory infectious diseases. This review aims to evaluate effectiveness and safety of SFJD for AECOPD.Methods...
poulet, christophe njock, makon-sébastien moermans, catherine louis, edouard louis, renaud malaise, michel guiot, julien
Within the non-coding genome landscape, long non-coding RNAs (lncRNAs) and their secretion within exosomes are a window that could further explain the regulation, the sustaining, and the spread of lung diseases. We present here a compilation of the current knowledge on lncRNAs commonly found in Chronic Obstructive Pulmonary Disease (COPD), asthma, ...
BAIRAGI, V K KANWADE, ARCHANA B
Published in
Sādhanā
Chronic lung disease, in which the airway gets obstructed, is known as Chronic Obstructive Pulmonary Disease (COPD). According to WHO, COPD kills more than 3 million people every year. Spirometry is used to diagnose COPD; has many limitations. There is a need for physiologically accurate and easy to perform diagnosis technology. Researchers confirm...
Nuwagira, Edwin Stadelman, Anna Baluku, Joseph Baruch Rhein, Joshua Byakika-Kibwika, Pauline Mayanja, Harriet Kunisaki, Ken M.
Published in
Tropical Medicine and Health
BackgroundPulmonary multi-drug-resistant tuberculosis (MDR TB) alters lung architecture and involves lengthy treatment duration, high pill burden, drug adverse effects, travel restrictions, and stigma. Literature about pulmonary function and health-related quality of life (QoL) of patients treated for MDR TB is limited. This study sought to determi...
tang, jun ramis-cabrer, daniel curull, víctor wang, xuejie qin, liyun mateu-jiménez, mercé duran, xavier pijuan, lara rodríguez-fuster, alberto espases, rafael aguiló
...
Background: The immune microenvironment plays a role in tumorigenesis. Chronic Obstructive Pulmonary Disease (COPD) is an independent risk factor for lung cancer (LC). We hypothesized that immune profile characterized by T regulatory (Treg), natural killer (NK), and plasma cells, as well as interleukin (IL)-10 and interferon-gamma, may differ withi...
Rehman, Anees ur Hassali, Mohamed Azmi Ahmad Harun, Sabariah Noor Abbas, Sameen Muneswarao, Jaya Ali, Irfhan Ali Bin Hyder Hussain, Rabia
Published in
Health and Quality of Life Outcomes
BackgroundCultural differences affect the administration and results of health status questionnaires. “Cross cultural adaptation” ensures retention of psychometric properties such as validity and reliability at an item and/or scale level.ObjectiveTo develop a Malaysian version of St George’s respiratory COPD specific questionnaire (SGRQ-CM), to eva...
Holmner, Åsa Öhberg, Fredrik Wiklund, Urban Bergmann, Eva Blomberg, Anders Wadell, Karin
Published in
BMC Medical Informatics and Decision Making
BackgroundMany telehealth systems have been designed to identify signs of exacerbations in patients with chronic obstructive pulmonary disease (COPD), but few previous studies have reported the nature of recorded lung function data and what variations to expect in this group of individuals. The aim of the study was to evaluate the nature of individ...
Donohue, James F. Kerwin, Edward Barnes, Chris N. Moran, Edmund J. Haumann, Brett Crater, Glenn D.
Published in
BMC Pulmonary Medicine
BackgroundRevefenacin, a once-daily, long-acting muscarinic antagonist delivered via standard jet nebulizer, increased trough forced expiratory volume in 1 s (FEV1) in patients with moderate to very severe chronic obstructive pulmonary disease (COPD) in prior phase 3 trials. We evaluated the efficacy of revefenacin in patients with markers of more ...
Lasman, N. Shalom, M. Turpashvili, N. Goldhaber, G. Lifshitz, Y. Leibowitz, E. Berger, G. Saltzman-Shenhav, G. Brom, A. Cohen, D.
...
Published in
BMC Pulmonary Medicine
BackgroundCOPD exacerbations have negative impact on patients’ survival. Several risk factors for grave outcomes of such exacerbations have been descried. Muscle dysfunction and mass loss were shown to impact negatively on prognosis and survival. Low activity of the enzyme ALT (Alanine amino-transferase) in the blood is a known indicator for sarcop...
